Breakthrough Cancer Care

March 15, 2020

Charles Farber, MD, PhD, hematologist/oncologist at Atlantic Hematology Oncology, located at Morristown Medical Center’s Carol G. Simon Cancer Center, and medical director of Oncology Research Network Development for Atlantic Health System, is leading a new study that will allow patients with a ...

Read more »

Missak Haigentz, Jr., MD, chief of hematology and oncology at Morristown Medical Center’s Carol G. Simon Cancer Center and medical director of Hematology and Oncology for Atlantic Health System, is leading a new study that will allow eligible head and neck cancer patients to get access to a type of ...

Read more »

Mohamad Cherry, MD, medical director of hematology for Atlantic Health System Cancer Care, is leading two clinical trials that use novel approaches to target treatment resistance in acute myeloid leukemia (AML). A phase 2 study is examining the response of an investigational drug that acts as a ...

Read more »

Six years ago, Pennsylvania resident John Snyder learned he had melanoma, an aggressive type of skin cancer. By last summer, he was running out of options — and time. “Nothing my doctors tried was working,” said John, 57. “It wasn’t looking good for me.” His local physicians then delivered ...

Read more »

Atlantic Health System is treating patients in a new Phase II clinical trial of CAR T-cell therapy at Morristown Medical Center. “A type of immunotherapy for lymphoma known as CAR T-cell therapy has generated a great deal of excitement within the medical community because it uses a patient’s own ...

Read more »

Atlantic Health System Cancer Care is dedicated to providing patients with access to the most promising and life-saving trials, research, and innovations in the communities where they live and work. Cutting-edge initiatives include the following: In affiliation with the Translational Genomics ...

Read more »